Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease

Technology appraisal guidance
Reference number: TA217
Published: 23 March 2011
Last updated: 20 June 2018

TA217 Alzheimer's disease - donepezil, galantamine, rivastigmine and memantine: appendix A - GE decision paper - April 2015

TA217 Alzheimer's disease - donepezil, galantamine, rivastigmine and memantine: appendix A - GE decision paper - April 2015

TA217 Alzheimer's disease - donepezil, galantamine, rivastigmine and memantine: appendix A - GE decision paper - April 2015
27 April 2015
(120.27 Kb 35 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 28 April 2015